Fatty Liver Disease (DBCOND0045266)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Silibinin
A flavonolignan with hepatoprotective effects used to treat toxic liver damage and as an adjunct in the management of chronic conditions such as cirrhosis and hepatitis.
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06585982
Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis and RCT StudyNo drug interventionstreatmentNot Availablerecruiting
NCT06588699
Digoxin in NASH (CODIN)treatment2not_yet_recruiting
NCT06589167
Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBVNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT04525833
Liver Disease and Other Systemic DiseasesNo drug interventionsNot AvailableNot Availableunknown_status
NCT04302051
Assessment of Fatty Liver With Thermo-acoustic DeviceNo drug interventionsNot AvailableNot Availablerecruiting
NCT05764811
SGLT-2 Inhibitor Effects on Cardiac and Hepatic Metabolic Profiles for the Diabetes Patients Combined With ObesitytreatmentNot Availablecompleted
NCT05898841
Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Loadtreatment4active_not_recruiting
NCT05880316
Prevalence of MAFLD Among Nurses and the Role of Intermittent FastingNo drug interventionstreatmentNot Availablerecruiting
NCT06487325
A Clinical Study of Ultrasound-derived Fat Fraction to Assess Metabolic Dysfunction-Associated Steatotic Liver DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04191044
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)No drug interventionsNot AvailableNot Availableunknown_status
NCT04367012
Fatty Liver Among Employees at Banha UniversityNo drug interventionsNot AvailableNot Availablecompleted
NCT05546450
Effect of Lyophilized Cornus Mas L. on Anthropometric and Biochemical Parameters in Metabolic Associated Fatty Liver Disease PatientsNo drug interventionstreatmentNot Availablecompleted
NCT06071923
Effect of Thyroid Disorders in Liver DiseasesNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT05881005
NAC- NAFLD and CushingNo drug interventionsdiagnosticNot Availablerecruiting
NCT05220956
Impact of Time-restricted Feeding in NAFLDNo drug interventionsscreeningNot Availablerecruiting
NCT04283942
Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose MetabolismNo drug interventionstreatmentNot Availablecompleted
NCT06302049
Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic Steatohepatitistreatment1 / 2recruiting
NCT01016418
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver DiseaseNo drug interventionstreatment1 / 2completed
NCT05076058
Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty LiverNo drug interventionstreatmentNot Availableunknown_status
NCT05966025
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)treatment2not_yet_recruiting
NCT06535048
Impact of Fatty Liver on Hepatitis B TherapyNot AvailableNot Availableactive_not_recruiting
NCT04175392
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitistreatment1 / 2terminated
NCT05421572
Epidemiological Survey on Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)No drug interventionsNot AvailableNot Availableunknown_status
NCT04496895
The Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in AdultsNo drug interventionstreatmentNot Availablerecruiting
NCT04844450
A Single and Multiple Ascending Dose Study of Subcutaneously Administered JNJ-75220795No drug interventionstreatment1completed
NCT05694923
Effect of Sodium Glucose Cotransporter Inhibitors Fatty Liver Disease Patients Fatigue AssessmenttreatmentNot Availablecompleted
NCT04066608
Prevalence of Advanced Fibrosis in Patients Living With HIVNo drug interventionsNot AvailableNot Availableenrolling_by_invitation